Healthcare / Health Information ServicesParis
$11.40
-0.06 (-0.52%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 26% · confianza 25%
FCF escenarios
weak_data · normalized FCF $22.4M · quality 48.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
50/100
C
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$157M
P/E
16.3x
↓EV/EBITDA
1.2x
↓ROE
3.4%
↑Gross Margin
86.1%
↑Debt/Equity
0.34
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+5.4%
FCF CAGR
+96.3%
FCF margin
12.1%
FCF / Net income
8.33x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $649.2M · net income $9.4M · FCF $78.3M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $649.2M | $649.2M | $654.5M | $616.0M | $555.2M |
| Net Income | $9.4M | $9.4M | $-14.7M | $-7.4M | $13.6M |
| EBITDA | $128.2M | $128.2M | $101.7M | $103.9M | $109.7M |
| EPS | 0.70 | 0.70 | -1.10 | -0.50 | 1.00 |
| Gross Margin | 86.1% | 86.1% | 95.5% | 95.4% | 85.3% |
| Operating Margin | 5.6% | 5.6% | 5.1% | 3.8% | 2.6% |
| Net Margin | 1.4% | 1.4% | -2.2% | -1.2% | 2.5% |
| Balance Sheet | |||||
| Debt/Equity | 0.34 | 0.34 | 0.35 | 0.34 | 0.32 |
| Current Ratio | 0.99 | 0.99 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $78.3M | $78.3M | $11.9M | $22.4M | $10.3M |
| Returns | |||||
| ROE | 3.4% | 3.4% | -5.6% | -2.7% | 4.8% |
| Valuation | |||||
| P/E | 16.29 | 16.29 | — | — | 16.52 |
| EV/EBITDA | 1.23 | 1.23 | 2.17 | 2.77 | 2.39 |
| P/B | 0.57 | 0.57 | 0.67 | 0.87 | 0.79 |
| Growth & Yield | |||||
| Revenue Growth | -0.8% | -0.8% | 6.3% | 10.9% | — |
| EPS Growth | 163.6% | 163.6% | -120.0% | -150.0% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
13.1%
EPS terminal req.
$1.01
Spread vs growth
150.6%
5Y implied EPS CAGR
11.8%
EPS terminal req.
$1.22
Spread vs growth
151.8%
10Y implied EPS CAGR
10.9%
EPS terminal req.
$1.97
Spread vs growth
152.7%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+5.1%
Start / end P/E
n/dx → n/dx
EPS bridge
-1.10 → 0.70
Residual
+5.1%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.